Tebotelimab Recruiting Phase 1 Trials for Endometrial Carcinoma / Triple Negative Breast Cancer / Biliary Tract Carcinoma / Malignant Neoplasm of Stomach Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT04178460A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment